19 May 2013
Keywords: corixa/gsk, initiatesph, trial, her-2/neu, breast, cancer, usa-based
Article | 09 June 2003
USA-based Corixa has initiated a Phase I clinical trial, in collaboration with GlaxoSmithKline Biologicals, to test the safety and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2003
16 June 2003
17 May 2013
© 2013 thepharmaletter.com